Further step in Bayer’s efforts to sharpen focus on core business

03-Dec-2019

Bayer has completed the sale of its 60 percent stake in chemical park operator Currenta to funds managed by Macquarie Infrastructure and Real Assets (MIRA). The two companies had entered into an agreement to this effect back in August. The closing conditions, including approval by the responsible ...

more

Agreements signed to divest Currenta and Animal Health

30-Oct-2019

Bayer has made progress in all key areas and is on track both operationally and strategically. “Bayer had a successful third quarter,” Werner Baumann, Chairman of the Board of Management, said on Wednesday during the news conference call on the quarterly figures. “We increased the Group’s sales ...

more

07-Aug-2019

Bayer and LANXESS sell their stakes in the chemical park operator Currenta to funds managed by Macquarie Infrastructure and Real Assets (MIRA). Both companies signed corresponding agreements with MIRA on August 6, 2019. The transaction still requires the approval of the responsible authorities. ...

more

25-Apr-2019

The Bayer Group achieved a strong start to the year in its operational business. “A major factor in this success was our agriculture business, while Pharmaceuticals also delivered encouraging performance,” said Werner Baumann, Chairman of the Board of Management, on Thursday when presenting the ...

more

Group sales and earnings increase

05-Sep-2018

Bayer successfully completed the biggest acquisition in its history in the second quarter of 2018, while operational performance improved, even without taking into account the newly acquired Monsanto business. Sales advanced at three of the four segments on a currency- and portfolio-adjusted ...

more

02-Aug-2018

BASF has closed the acquisition of a range of businesses and assets from Bayer. The transaction is a strategic complement to BASF’s crop protection, biotech and digital farming activities and marks its entry into seeds, non-selective herbicides and nematicide seed treatments. “This strategic move ...

more

Another record year for Pharmaceuticals

28-Feb-2018

In 2017, Bayer’s operational business was at the prior-year level. The company made good progress strategically. “We took major steps toward the proposed acquisition of Monsanto,” Management Board Chairman Werner Baumann said on Wednesday at the Financial News Conference in Leverkusen. ...

more

Covestro deconsolidated

26-Oct-2017

The third quarter of 2017 marked a period of further strategic and operational progress for the Bayer Group. “Last quarter we took some important strategic steps,” said Werner Baumann, Chairman of the Board of Management, when he presented the interim report for the third quarter on Thursday. ...

more

Growth momentum across all segments

28-Apr-2017

The Bayer Group got off to a very successful start to 2017 and generated strong sales and earnings growth in the first quarter. “At Pharmaceuticals, we once again benefited from the very good performance of our key growth products,” CEO Werner Baumann said when he presented the interim report for ...

more

22-Mar-2017

Record-high M&A activity is set to transform the chemicals industry in 2017, according to A.T.Kearney’s new Chemicals Executive M&A Report. More than $300 billion of chemicals M&A deals are in the pipeline of which four pending mega deals represent 75 percent. Each of these large deals ...

more